Breast Cancer Trial, Recruiting NCT07407153 Sponsor: International Agency for Research on Cancer Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07407153
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are eligible for breast cancer screening under the national screening programme in their country, or who have had a lump found in their breast during a clinical examination.

Who may not be able to join:

  • Women who have already had a breast cancer screening in the last three years.
  • Women who have a known history of breast cancer or have previously had breast surgery.
  • Women who have symptoms that suggest a high likelihood of breast cancer, such as an open or ulcerated lump, or blood-stained discharge from the nipple.
  • Women who have a serious or debilitating illness.
  • Women who are unable to give informed consent due to certain mental health conditions.
  • Women who, in the opinion of the trial investigator, are unlikely to be able to follow the study procedures or attend required follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
International Agency for Research on Cancer
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
28 February 2028

Where this trial is recruiting

🇮🇩 Indonesia

Primary endpoints

Positive predictive value and negative predictive value of CBE by ultrasound triaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov